Aprea Therapeutics, Inc.
APRE
Revenue
0.00
0.000.00%
-Assets
29.96M
▼-3.24M▼-9.75%
3 Months ChangeLiabilities
3.95M
▼-276.57k▼-6.54%
3 Months ChangeFree Cash Flow
-3.94M
▲3.61M▲47.79%
48 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-23
Form 8-K
ID: 0001558370-24-013486
2024-10-09
Form 8-K
ID: 0001104659-24-107219
2024-08-12
Form 8-K
ID: 0001558370-24-011808
2024-08-12
Form 10-Q
ID: 0001558370-24-011806
2024-06-20
Form 8-K
ID: 0001104659-24-073396
2024-06-17
Form 8-K
ID: 0001558370-24-009225
2024-05-14
Form 8-K
ID: 0001558370-24-008070
2024-05-14
Form 10-Q
ID: 0001558370-24-008069
2024-04-10
Form 8-K
ID: 0001558370-24-004927
2024-03-26
Form 8-K
ID: 0001558370-24-003887